CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- CERT Other Certification
- 8-A12B Other Registration of Securities
- 8-K Event Shareholder vote results · Other events
- SD Other Specialized Disclosure
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- POSASR Other POSASR
- 144 Insider Sale of Securities
- 4 Option exercise SVP Fin. - Global Controller acquired 2,658 shares (option exercise)
- 4 Option exercise EVP&Pres, Merck Animal Heallth acquired 27,126 shares (option exercise)
- 4 Option exercise EVP - Chief Strategy Officer acquired 887 shares (option exercise)
- 4 Option exercise President, U.S. Market acquired 912 shares (option exercise)
- 10-Q Report Quarterly Report
- 4 Option exercise President, Human Health Int?l acquired 2,262 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise SVP Fin. - Global Controller acquired 381 shares (option exercise)
Page 15 of 152 · 3,038 filings